Rebecca S. Cook - Concepedia

Author

Rebecca S. Cook

Vanderbilt University ORCID

Also Known As

Cook, Rebecca S, Kuba, María G., R S Cook, R.S. Cook, Rebecca Cook, Rebecca S Cook, Rebecca S. Cook

255

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center Breast Cancer Research Foundation University of North Carolina at Chapel Hill VA Tennessee Valley Healthcare System

About

Rebecca S. Cook is an author at Vanderbilt University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	2.7K
2	Engineering	5	5	202
3	Health Sciences	3	3	503
4	Biochemistry	2	2	411
5	Natural Sciences	1	1	101

Rebecca S. Cook

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Clinical Cancer Research	2015	546
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Cancer Discovery	2013	467
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase Joan T. Garrett, Maria G. Olivares, Cammie Rinehart, Proceedings of the National Academy of Sciences Pi3k PathwayTumor BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2011	455
MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors Alexa B. Turke, Youngchul Song, Carlotta Costa, Cancer Research	2012	355
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer Deanna N. Edwards, Verra M. Ngwa, Ariel Raybuck, Journal of Clinical Investigation Breast OncologyImmunologyTumor CellsCancer BiologyTumor Biology	2020	329
Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer Alex J. Walsh, Rebecca S. Cook, H. Charles Manning, Cancer Research Breast OncologyOncologic ImagingMetabolic RemodelingTumor BiologyEarly-treatment Response	2013	326
Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast Cancer Alex J. Walsh, Rebecca S. Cook, Melinda E. Sanders, Cancer Research	2014	310
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance Justin M. Balko, Rebecca S. Cook, David Vaught, Nature Medicine Breast OncologyResidual Breast CancersMedicinePathologyCancer Genomics	2012	255
Mutant <i>PIK3CA</i> accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies Ariella B. Hanker, Adam D. Pfefferle, Justin M. Balko, Proceedings of the National Academy of Sciences	2013	193
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers David L. Elion, Max E. Jacobson, Donna J. Hicks, Cancer Research	2018	175

Page 1